Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

74.06 -0.19 (-0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Astrazeneca Plc ADR

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
33 34 Next >
AstraZeneca's Asthma Treatment Scores European Approval
 
Via Benzinga
AstraZeneca's COVID-19 Antibody Treatment Scores Approval In Europe
 
Via Benzinga
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
 
Via Benzinga
AstraZeneca's Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial
 
Via Benzinga
Top Financial Stories Tuesday, September 13: Elon Musk's Takeover Set To Get Twitter Shareholder Approval, Intel Slashes Mobileye IPO Valuation, Goldman Sachs To Layoff About 500 Jobs And More...
Wall Street Journal 
Via Benzinga
US Judge Dismisses Shareholder Lawsuit Over AstraZeneca's COVID-19 Vaccine Disclosures: Report
 
Via Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
 
Via Benzinga
AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer
 
Via Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
 
Via Benzinga
AstraZeneca Imfinzi Combo Scores FDA Approval As First Immunotherapy Regimen For Biliary Tract Cancer
 
Via Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
 
Via Benzinga
Here's How Much $1000 Invested In AstraZeneca 5 Years Ago Would Be Worth Today
AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 5.5% on an annualized basis producing an average annual return of 15.24%. Currently, AstraZeneca has a market... 
Via Benzinga
AstraZeneca Scores Its First Global Approval For Antibody Evusheld As COVID-19 Treatment
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Upgrades 
Via Benzinga
Valneva Posts Additional Encouraging Data From COVID-19 Booster Trial
 
Via Benzinga
AstraZeneca Touts Positive Farxiga Data, Seeks Label Expansion In Heart Failure
AstraZeneca Plc (NASDAQ: AZN) laid out the details of the Farxiga's performance in another heart failure patient population at the European Society of Cardiology Congress. 
Via Benzinga
Week In Review: China And The US May Settle De-Listing/Accounting Impasse
China and the US are close to solving the accounting rules crisis that threatens to de-list 261 China companies from US exchanges. The list of affected biopharma companies includes BeiGene, Legend Bio,... 
Via Talk Markets
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
Back-To-Back Three Japanese Approvals For AstraZeneca's Rare Disease Treatments
 
Via Benzinga
AstraZeneca's CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions
In a Reuters report, AstraZeneca Plc's (NASDAQ: 
Via Benzinga
Sorrento Shares Pop After Interim Data From Lung Cancer Trial
Sorrento Therapeutics Inc (NASDAQ: SRNE) announced positive results from a pivotal study of Abivertinib on 209 response evaluable, heavily pretreated NSCLC patients by an IRC assessment with matured... 
Via Benzinga
Amgen Touts Positive Data From Soliris-Based Biosimilar For Rare Blood Disorder
 
Via Benzinga
Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December
  
Via Benzinga
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
3 Top Stocks to Invest In Right Now
Every investor is looking for the top stocks to invest in. These three options will provide you with both offense and defense. 
Via InvestorPlace
Benzinga Before The Bell: Elon Musk May Get Info It Wants From Twitter, Apple To Lay Off 100 Recruiter Contractors, Saudi's Investment Fund Picks Stocks Of US Big Tech And Other Top Financial Stories Tuesday, August 16
Reuters 
Via Benzinga
UK Government Will Not Buy More AstraZeneca's COVID-19 Treatment
 
Via Benzinga
AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use
 
Via Benzinga
Benzinga Before The Bell: YouTube Plans Streaming Marketplace, Drug Pricing Bill Passes Congress, Bitcoin Could Surge To All-Time High Soon And Other Top Financial Stories Monday, August 15
Reuters PlayAGS Shares Pop Premarket On Takeover Offer At 33% Premium 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.